SEER Inquiry System - View

Question: 20130017 Status
Final

References
Source 1:   Heme & Lymph Manual & DB
pgs:  
Notes:  
Source 2:  
pgs:  
Notes:  


Question
Reportability--Heme & Lymphoid Neoplasms: Is reactive thrombocytosis reportable? See Discussion.

Discussion
The doctor’s impression: “Thrombocytosis, mild without other obvious hematologic difficulty. I would be most suspicious for early iron deficiency related to her prior menometrorrhagia. Would limit initial evaluation to iron studies, review of peripheral smear, and hepatic profile.”

Answer
For cases diagnosed 2010 and forward, access the Hematopoietic Database at http://seer.cancer.gov/seertools/hemelymph.

Reactive thrombocytosis is not reportable and is not an alternative name for essential thrombocythemia [9962/3].

Only the following are listed as alternate names for essential thrombocythemia in the Heme DB:

  • Essential hemorrhagic thrombocythemia
  • Essential thrombocytosis
  • ET
  • Hemorrhagic thrombocythemia
  • Idiopathic hemorrhagic thrombocythemia
  • Idiopathic thrombocythemia
  • Idiopathic thrombocytosis
  • Primary thrombocythemia
  • Primary thrombocytosis
  • Thrombocythemia vera
SEER*Educate provides training on how to use the Heme Manual and DB. If you are unsure how to arrive at the answer in this SINQ question, refer to SEER*Educate to practice coding hematopoietic and lymphoid neoplasms. Review the step-by-step instructions provided for each case scenario to learn how to use the application and manual to arrive at the answer provided. https://educate.fhcrc.org/LandingPage.aspx.

History


Last Updated
07/01/2014

Date Finalized
04/30/2013